NXPI - NXP Semiconductors N.V.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
80.79
+1.65 (+2.08%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close79.14
Open80.05
Bid80.81 x 1000
Ask80.90 x 800
Day's Range79.76 - 81.94
52 Week Range67.62 - 125.93
Volume8,818,895
Avg. Volume5,007,238
Market Cap23.874B
Beta (3Y Monthly)1.18
PE Ratio (TTM)10.28
EPS (TTM)7.86
Earnings DateFeb 5, 2019 - Feb 11, 2019
Forward Dividend & Yield1.00 (1.25%)
Ex-Dividend Date2018-12-13
1y Target Est100.25
Trade prices are not sourced from all markets
  • Health care, retail, biotech & emerging markets in the bl...
    CNBC Videos21 hours ago

    Health care, retail, biotech & emerging markets in the bl...

    The "Halftime Report" traders take investors through some of the day's biggest movers.

  • GlobeNewswire2 days ago

    NXP Semiconductors Announces Conference Call to Review Fourth Quarter and Full Year 2018 Financial Results and Availability of Historical End-Market Data

    EINDHOVEN, Netherlands, Jan. 17, 2019 -- NXP Semiconductors N.V. (NASDAQ: NXPI) today announced it will release financial results for the fourth quarter and the full year of.

  • Markit2 days ago

    See what the IHS Markit Score report has to say about NXP Semiconductors NV.

    # NXP Semiconductors NV ### NASDAQ/NGS:NXPI View full report here! ## Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate ## Bearish sentiment Short interest | Positive Short interest is extremely low for NXPI with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting NXPI. ## Money flow ETF/Index ownership | Neutral ETF activity is neutral. The net inflows of $8.91 billion over the last one-month into ETFs that hold NXPI are not among the highest of the last year and have been slowing. ## Economic sentiment PMI by IHS Markit | Negative According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • How NXP Semiconductors Shares Fell 37% in 2018
    Motley Fool5 days ago

    How NXP Semiconductors Shares Fell 37% in 2018

    The long-awaited merger with Qualcomm fell apart at the goal line.

  • NXP Partners Kalray on ADAS Efforts, Ups Game in Self-Drive
    Zacks8 days ago

    NXP Partners Kalray on ADAS Efforts, Ups Game in Self-Drive

    NXP Semiconductors (NXPI) collaborates with Kalray to build a platform, which will include roadmaps and development for level 4 and 5 cars while addressing the requirements of level 2 and 3 cars.

  • Markit10 days ago

    See what the IHS Markit Score report has to say about NXP Semiconductors NV.

    # NXP Semiconductors NV ### NASDAQ/NGS:NXPI View full report here! ## Summary * ETFs holding this stock are seeing positive inflows * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate ## Bearish sentiment Short interest | Positive Short interest is extremely low for NXPI with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting NXPI. ## Money flow ETF/Index ownership | Positive ETF activity is positive. Over the last month, growth of ETFs holding NXPI is favorable, with net inflows of $13.11 billion. This is among the highest net inflows seen over the last one-year and the rate of additional inflows appears to be increasing. ## Economic sentiment PMI by IHS Markit | Negative According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Technology sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. ## Credit worthiness Credit default swap CDS data is not available for this security. Please send all inquiries related to the report to score@ihsmarkit.com. Charts and report PDFs will only be available for 30 days after publishing. This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Benzinga11 days ago

    Goldman Sachs Shares Semiconductor Stock Picks For A Challenging 2019

    The deceleration witnessed in the semiconductor space in the second half of 2018 is likely to continue into 2019, making it another challenging year for the stocks, according to Goldman Sachs. The Analyst ...

  • InvestorPlace11 days ago

    Is It Time to Sell Celgene Stock After the Bristol-Myers Squibb Offer?

    When Bristol-Myers Squibb (NYSE:BMY) announced on Jan. 3 that it would acquire Celgene (NASDAQ:CELG) for $74 billion, it gave year-long suffering CELG stock owners an exit point. The only decision Celgene shareholders need to consider next is if they should sell the stock now for around $85 or tender the stock for $50 in cash and one BMY common share for each CELG share held. ### Celgene Stock Discounted From Buyout Price CELG stock trades at an $11.89 discount to the buyout price for two main reasons. First, markets are discounting the possible risk on the deal not closing or getting delayed. Look at NXP Semiconductors (NASDAQ:NXPI) when Qualcomm (NASDAQ:QCOM) first offered to buy the former for $127.50. For months, NXPI stock did not trade very close to the offer price because the markets priced in the risks of the deal failing. While waiting for antitrust approval from China, the company extended the deal several times. Ultimately, the deal fell apart when the Chinese government did not approve the proposed buyout in time. InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Small-Cap Stocks With Big Growth Potential In 2019 BMY's cash and share offer is the second reason Celgene stock trades at a discount to the takeover offer price. Bristol-Myers' stock fell from around $53 to below $45, albeit briefly, when the company announced the offer. Fundamentally, it has plenty of cash on hand and may easily raise debt to pay for Celgene. At a debt-to-equity ratio of 0.54X, it has the room to lever its balance sheet. Shareholders will allow for share dilution to get Celgene's IP and product portfolio. ### Celgene Bought Out at a Discount Its forward price-to-earnings ratio is 8.4X, even after shares soared 35% last week, meaning CELG stock still trades at a discount. This is especially true when you consider that the stock is still 23% below its 52-week high. Still, Celgene's management levered the company's balance sheet enough to scare off investors. Its acquisition of Juno Therapeutics in January 2018 cost it $9 billion but raised its debt-to-equity to four times. Fundamentally, CELG's cash cow for over the last decade, Revlimid, which treats Multiple Myeloma, faces stiff competition from more agile, innovative competitors. It is only a matter of time before they release new products into first-line multiple myeloma therapy, eroding Celgene's Revlimid sales. ### Post-Buyout Expectations Celgene's poor leadership led to the underperformance in its shares. The company failed to advance its pipeline of drugs in 2018. When BMY takes over, it will probably restructure Celgene management while cutting operating costs. For those two reasons, investors tendering CELG stock for BMY should expect BMY stock to trade higher in the years to come. * 10 Oversold Stocks Due for a Bounce Currently, Celgene shareholders do not earn any dividend while BMY shareholders get a dividend yielding 3.5%. If BMY stock falls in the months to come, lifting the dividend yield to levels above that of Pfizer (NYSE:PFE), at 3.35% and Merck & Co., Inc. (NYSE:MRK), at 2.88%, Celgene stock investors may even want to switch their shares for BMY stock on the open market. ### Bottom Line on CELG Stock Celgene stockholders could wait until the deal is closed to make the most or sell now to avoid the buyout risks as previously mentioned. But by selling now, investors leave a big discount on the table. If BMY is getting Celgene for too good a price, a white knight may come to bid a higher price. There is no right decision on whether to sell Celgene stock now or to hold it until the deal. Patient investors who are bullish on BMY's prospects will want to wait for the deal's completion, while skittish investors could sell now and look for other biotech stock ideas trading at a discount. As of this writing, Chris Lau owned shares of NXPI. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy Down 20% in December * 5 Chinese Stocks to Avoid Now (But Buy Later) * 3 Big Gainers That Easily Could Be the Best Stocks to Buy Compare Brokers The post Is It Time to Sell Celgene Stock After the Bristol-Myers Squibb Offer? appeared first on InvestorPlace.

  • Reuters11 days ago

    NXP teams with French company on self-driving car chips

    NXP has long supplied chips to the automotive market and boasts deep ties in that industry, one reason that Qualcomm Inc (QCOM.O) agreed to pay $44 billion for the firm even though the deal was eventually abandoned. Ever since the Qualcomm deal fell apart last year after failing to win Chinese regulatory approval, NXP has sought to chart a new path while larger rivals like its erstwhile suitor and Nvidia Corp (NVDA.O) push deeper into the nascent self-driving car computer market with increasingly powerful processors. To obtain the computing muscle needed to help cars "see," NXP said on Tuesday at the Consumer Electronics Show in Las Vegas it will team with a 10-year-old French chip firm that started in the aerospace sector.

  • Reuters11 days ago

    NXP teams with French company on self-driving car chips

    NXP has long supplied chips to the automotive market and boasts deep ties in that industry, one reason that Qualcomm Inc agreed to pay $44 billion for the firm even though the deal was eventually abandoned. Ever since the Qualcomm deal fell apart last year after failing to win Chinese regulatory approval, NXP has sought to chart a new path while larger rivals like its erstwhile suitor and Nvidia Corp push deeper into the nascent self-driving car computer market with increasingly powerful processors.

  • GlobeNewswire11 days ago

    NXP and Kalray Enter Partnership to Develop Platform for Safe, Reliable Autonomous Driving

    NXP Semiconductors N.V. (NXPI), a technology and market leader in next-generation automotive technologies, today announced a new strategic partnership with Kalray (Euronext Growth Paris – ALKAL), a pioneer in processors for new intelligent systems. The partnership will combine NXP’s scalable portfolio of functional safety products for ADAS and Central Compute with Kalray’s high-performance intelligent MPPA® (Massively Parallel Processor Array) processors. The new platform is significant because it addresses the performance, safety and near-term commercial needs of levels 2 and 3 driving with an eye to longer-term release in level 4 and 5 autonomous vehicles.

  • GlobeNewswire11 days ago

    NXP Brings Dolby Atmos® and DTS:X® to the Masses with its New Immersiv3D Audio Solution

    News Highlights Announces support for immersive audio support with Dolby Atmos® and DTS:X® on an Arm® Cortex®-A53Announces advanced hardware and software architecture.

  • Can NXP (NXPI) Keep the Earnings Surprise Streak Alive?
    Zacks12 days ago

    Can NXP (NXPI) Keep the Earnings Surprise Streak Alive?

    NXP (NXPI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

  • Is NXP Semiconductors (NXPI) a Great Stock for Value Investors?
    Zacks12 days ago

    Is NXP Semiconductors (NXPI) a Great Stock for Value Investors?

    Is NXP Semiconductors (NXPI) a great pick from the value investor's perspective right now? Read on to know more.

  • What Investors Should Know About NXP Semiconductors N.V.’s (NASDAQ:NXPI) Financial Strength
    Simply Wall St.13 days ago

    What Investors Should Know About NXP Semiconductors N.V.’s (NASDAQ:NXPI) Financial Strength

    NXP Semiconductors N.V. (NASDAQ:NXPI), a large-cap worth US$22b, comes to mind for investors seeking a strong and reliable stock investment. Market participants who are conscious of risk tend to search Read More...

  • Forget Broadcom, NXP Semiconductors Is a Better Value Stock
    Motley Fool16 days ago

    Forget Broadcom, NXP Semiconductors Is a Better Value Stock

    The Dutch specialist in automotive and industrial chips really shouldn't be this cheap.

  • Apple shares dive; rare revenue warning drags global markets
    Reuters16 days ago

    Apple shares dive; rare revenue warning drags global markets

    Global financial markets felt the shockwaves as Apple shares logged their biggest intra-day percentage fall in six years, sending the company's stock market value to under $700 billion (554 billion pounds), well below its $1.1 trillion October peak. After Apple's first revenue warning in nearly 12 years, investors also dumped chipmakers and tech stocks and flocked to perceived safe havens like U.S. Treasuries and the Japanese yen. A senior White House economic adviser said he expected trade uncertainty to hit earnings at many U.S. companies, but that sales at Apple and others with large exposure to China would recover once Washington and Beijing strike a trade deal.

  • What Qualcomm Investors Should Watch For
    Market Realist19 days ago

    What Qualcomm Investors Should Watch For

    Among semiconductor stocks, Qualcomm (QCOM) may have been hit the hardest by US-China trade tension. The trade war impeded the company’s long-pending NXP Semiconductors (NXPI) acquisition and forced Qualcomm to walk out of the deal with a $2 billion termination fee. With the acquisition, Qualcomm was aiming to diversify away from smartphones, from which it earns much of its revenue.

  • Better Buy: NXP Semiconductors vs. Apple
    Motley Fool22 days ago

    Better Buy: NXP Semiconductors vs. Apple

    This was an easy win.

  • What Intel Could Gain If It Sells McAfee
    Market Realist23 days ago

    What Intel Could Gain If It Sells McAfee

    Private equity company Thoma Bravo is in talks to acquire McAfee, according to a CNBC report citing people familiar with the matter. McAfee is a security software company owned jointly by Intel (INTC) and investment company TPG Capital.

  • NXP Is Selling Below What It Bought Itself For
    GuruFocus.com23 days ago

    NXP Is Selling Below What It Bought Itself For

    NXP Semiconductors (NXP), one of the world's largest semiconductor companies, has lost 42% of its stock price this year. The company's fumbled merger with Qualcomm (QCOM) has made a contribution to its price decline. Warning! GuruFocus has detected 5 Warning Signs with SSI.

  • InvestorPlace23 days ago

    Why Qualcomm Stock Should Be a Mainstay In Any 5G Portfolio

    San Diego-based Qualcomm (NASDAQ:QCOM) has made the news in 2018 with its tit-for-tat legal battle with Apple (NASDAQ:AAPL) over royalties as well as the rejection by the U.S. Justice Department of its attempt to acquire NXP Semiconductor (NASDAQ:NXPI), the microchip designer. Coupled with the broader market decline, the legal uncertainty surrounding QCOM stock has weighed on its price since early October. Qualcomm is the largest chipmaker for smartphones and its chipsets account for about two thirds of total revenue.

  • InvestorPlace24 days ago

    5G Will Soon End the Winter of Discontent for Qualcomm Stock

    Qualcomm (NASDAQ:QCOM) has suffered years of stagnation. QCOM stock has long remained range-bound as bursts of short-term optimism gave way to disappointment. QCOM will play a critical role in bringing 5G to the market.

  • Checking In on Broadcom’s Stock Buyback
    Market Realist24 days ago

    Checking In on Broadcom’s Stock Buyback

    As we’ve discussed, Qualcomm (QCOM) announced the semiconductor industry’s biggest stock buyback, of $30 billion, to revive investors’ confidence in its potential to deliver earnings growth organically without acquiring NXP Semiconductors (NXPI). Broadcom (AVGO), on the other hand, has been increasing its profit margins and cash flow by acquiring distressed companies with high cash flow. Its strategy is to increase its cash flow and give returns to shareholders through dividends, stock buybacks, and strategic acquisitions.

  • How Successful Has Qualcomm’s $30 Billion Buyback Been?
    Market Realist24 days ago

    How Successful Has Qualcomm’s $30 Billion Buyback Been?

    Qualcomm (QCOM) is a leader in the mobile market, with its chips powering 95% of the world’s smartphones. Amid the Apple headwinds, Broadcom (AVGO) made a hostile takeover bid for Qualcomm, but the deal was blocked by Donald Trump. Despite avoiding the Broadcom takeover, Qualcomm was pressured by shareholders to grow its EPS.